bit.bio Expands Executive Team with Appointment of Przemek Obloj as Chief Financial Officer

Contributed by: Business Wire

Logo

Tags

Professional Services

Health

Genetics

Other Health

Finance

General Health

Biotechnology

bit.bio

More Like This

bit.bio Raises $30 Million Led by M&G Investments to Focus on Tools for the Research, Drug Discovery and Cell Therapy Markets

Nobel Laureate Thomas Südhof and bit.bio CEO Mark Kotter to Lead Fireside Chat on Programming Human Cells at SynBioBeta

(Graphic: Business Wire)

bit.bio Wins Landmark Patent Defence for Groundbreaking opti-ox™ Cell Programming Technology

bit.bio Announced as Inaugural Partner of Ginkgo Bioworks’ New Technology Network

GlobeNewswire associated0

4BIO Capital Strengthens Advisory Board and Investment Team

bit.bio's cell therapy pipeline November 2023 (Graphic: Business Wire)

bit.bio Unveils Cell Therapy Pipeline, Including Lead Candidate for Acute Liver Failure, and Significantly Expands Scientific Advisory Board with Global Experts in Cell Therapy

PR Newswire associated0

Peptone Expands Leadership Team with Key Executive Hires

bit.bio Announces First Project Within Multi-Year Collaboration Agreement with The Michael J. Fox Foundation (MJFF) to Generate Human Cell Products for Research and Drug Discovery in Parkinson’s disease